Skip to main content
. 2008 Oct 6;13(7):1279–1290. doi: 10.1111/j.1582-4934.2008.00519.x

Table 2.

Antibodies used for immunohistochemical labeling to differentiate cholangiocellular carcinoma (CCC) from hepatocellular carcinoma (HCC) (other than anti-FP2)

Antibody Source Clone Dilution Cellular location
Anti-CK 7 Dako Corp., Carpinteria, CA OV-TL12/30 1:100 Cytoplasmic
Anti-CK 19 Dako Corp., Carpinteria, CA RCK108 1:100 Cytoplasmic
Anti-CEA Dako Corp., Carpinteria, CA Polyclonal 1:400 Cytoplasmic vs. pericanalicular
Hep Par 1 Dako Corp., Carpinteria, CA OCH 1E5.2.10 1:100 Cytoplasmic, granular

CK7: Cytokeratin 7; CK19: Cytokeratin 19, CEA: Carcinoembryonic antigen, Hep Par 1: Hepatocyte Paraffin 1. Selected cases were also stained with alpha-fetoprotein and CD10 (data not shown).